1. Introduction {#sec1}
===============

*Bacillus subtilis* is a Gram-positive bacteria model bacterium, which has been widely used both for metabolic mechanism investigation and metabolic engineering ([@bib51]). *B. subtilis* has a clear genetic background and a series of genome engineering tools, which enable *B. subtilis* as an important chassis for bioproduction ([@bib4]; [@bib19]; [@bib36]; [@bib38]; [@bib41]; [@bib48]; [@bib49]). The advantages of using *B. subtilis* for nutraceutical and recombinant protein bioproduction are as follows: 1) Generally Regarded As Safe (GRAS) status certified by the US Food and Drug Administration for production ([@bib1]), 2) efficient protein secretion system and molecular chaperone system for protein secretion ([@bib37]; [@bib15]), 3) not susceptible for phage infection during industrial fermentation. Rapid growth of *B. subtilis* chassis is beneficial for shortening the fermentation period and enhancing production of target product. However, engineered *B. subtilis* usually has reduced growth rate compared with initial strain, especially after intensively rewiring the metabolic pathway, which seriously hinders its application for bioproduction ([@bib12]). Therefore, developing fast-growing *B. subtilis* is of great significance for improved bioproduction.

Adaptive laboratory evolution (ALE) is an important strategy to improve the fitness of microorganisms through selected environmental conditions and was widely used in metabolic engineering ([@bib28]; [@bib22]; [@bib8]; [@bib31]; [@bib13]). Five major application areas of ALE are growth rate optimization ([@bib34]; [@bib30]), increasing tolerance of the strain ([@bib32]; [@bib44]; [@bib29]), increase of substrate utilization ([@bib18]; [@bib14]), increase of product yield/titer ([@bib13]; [@bib23]; [@bib43]) and mechanism discovery ([@bib40]; [@bib17]). Fast growth phenotypes of *Escherichia coli* have been obtained through ALE, and the underlying mechanism has been studied ([@bib21]; [@bib26]; [@bib27]; [@bib46]; [@bib35]). The evolved strains' specific growth rate is 1.6-fold of the starting strain ([@bib21]). ALE was also used to effectively recover growth for genome reduced *E. coli* ([@bib8]). Therefore, using ALE for enhancing cell growth rate in *E. coli* provided potential strategies for improving *B. subtilis* cell growth. In addition, the growth of *B. subtilis* is in a suboptimal state because it has invested valuable cellular resources to adapt to environment changes; at the same time, the synthesis of some enzymes in the central metabolic pathway is excessive, causing metabolic burden on cell growth ([@bib12]; [@bib9]). These suggest that the specific growth rate of *B. subtilis* can be theoretically improved by engineering cellular resource allocation.

In this study, the model Gram-positive bacterium *B. subtilis* 168 (BS168) was chosen as starting strain for fast growth chassis development via rational gene knockout and adaptive laboratory evolution. Specifically, *B. subtilis* BS01, BS02, and BS03 with improved growth rate were obtained through knocking out of *oppD*, *hag*, and *flgD* genes. Next, ALE was performed, yielding strains A28 and A40 with improved growth rate. On the basis of evolved strain A40, gene knockout was further carried out, yielding strain with further growth increase. Finally, intracellular product (ribonucleic acid, RNA), extracellular product (acetoin), and recombinant proteins (green fluorescent protein (GFP) and ovalbumin) were used to test the bioproduction efficiency of these strains ([Fig. 1](#fig1){ref-type="fig"}). The developed fast-growing *B. subtilis* strains and strategies used for developing these strains should be useful for improving bioproduction efficiency and constructing other industrially important bacterium with faster growth phenotype.Fig. 1Flowchart of developing rapid growing *B. subtilis* for improved bioproduction. BS168 was chose as starting strain. Rational gene knockout and ALE were performed in parallel. Genes *oppD, hag,* and *flgD* those can potentially increase specific growth rate after deletion were selected. ALE was performed via continuously taking exponentially growing *B. subtilis* from one round cell culture for inoculation into fresh M9 medium in next round culture in shake flask until obtaining *B. subtilis* with fast growth phenotype. Then, using the evolved strain A40 as host, *oppD, hag,* and *flgD* gene knockout was implemented, respectively. The representative strains of each step were selected, which have gradient increase of specific growth rate. At last, bioproduction efficiency of *B. subtilis* with fast growth phenotypes was tested using intracellular product ribonucleic acid (RNA), extracellular product acetoin, and recombinant proteins including green fluorescent protein (GFP) and ovalbumin as examples. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)Fig. 1

2. Methods {#sec2}
==========

2.1. Plasmids and strains {#sec2.1}
-------------------------

The strains and plasmids used in this study are listed in [Table 1](#tbl1){ref-type="table"}. The engineered *B. subtilis* strains were derived from BS168. *E. coli* JM109 used as cloning host and Gibson assembly method were used to construct all the plasmids. Genes were knocked out by homologous recombination. The molecular biology enzymes and kits were purchased from TaKaRa Biomedical Technology (Beijing, China) and Sangon Biotech (Shanghai, China), respectively. Primers synthesis, sequencing and ovalbumin gene synthesis were all performed by Genewiz (Suzhou, China).Table 1Strains and plasmids used in this study.Table 1NameCharacteristicsreference*Strains*BS168*Bacillus subtilis* 168Lab stockBS01BS168 derivate, BS168*ΔoppD*This studyBS02BS168 derivate, BS168*Δhag*This studyBS03BS168 derivate, BS168*ΔflgD*This studyA28BS168 derivate, evolving in glucose M9 medium cultures for more than 800 generationsThis studyA40BS168 derivate, evolving in glucose M9 medium cultures for more than 1000 generationsThis studyA4001A40 derivate, A40*ΔoppD*This studyA4002A40 derivate, A40*Δhag*This studyA4003A40 derivate, A40*ΔflgD*This studyBS04BS168 derivate, expressing *pfkA, alsSD* gene under the control of P~43~ promoter via the plasmid p43NMKThis studyA2801A28 derivate, expressing *pfkA, alsSD* gene under the control of P~43~ promoter via the plasmid p43NMKThis studyA4006A40 derivate, expressing *pfkA, alsSD* gene under the control of P~43~ promoter via the plasmid p43NMKThis studyA4007A4003 derivate, expressing *pfkA, alsSD* gene under the control of P~43~ promoter via the plasmid p43NMKThis studyBS06BS168 derivate, expressing green fluorescent protein (GFP) sequence under the control of P~43~ promoter via the plasmid p43NMK-N*gfp*This studyBS07BS03 derivate, expressing green fluorescent protein (GFP) sequence under the control of P~43~ promoter via the plasmid p43NMK-N*gfp*This studyA2802A28 derivate, expressing green fluorescent protein (GFP) sequence under the control of P~43~ promoter via the plasmid p43NMK-N*gfp*This studyA4008A40 derivate, expressing green fluorescent protein (GFP) sequence under the control of P~43~ promoter via the plasmid p43NMK-N*gfp*This studyA4009A4003 derivate, expressing green fluorescent protein (GFP) sequence under the control of P~43~ promoter via the plasmid p43NMK-N*gfp*This studyBS08BS168 derivate, expressing ovalbumin and green fluorescent protein (GFP) sequence under the control of P~43~ promoter via the plasmid pHT01This studyBS09BS03 derivate, expressing ovalbumin and green fluorescent protein (GFP) sequence under the control of P~43~ promoter via the plasmid pHT01This studyA2803A28 derivate, expressing ovalbumin and green fluorescent protein (GFP) sequence under the control of P~43~ promoter via the plasmid pHT01This studyA4010A40 derivate, expressing ovalbumin and green fluorescent protein (GFP) sequence under the control of P~43~ promoter via the plasmid pHT01This studyA4011A4003 derivate, expressing ovalbumin and green fluorescent protein (GFP) sequence under the control of P~43~ promoter via the plasmid pHT01This study*Plasmids*p43NMKAMP, Kana, *E. coli-B. subtilis* shuttle vectorLab stockpHT01AMP, CmR, *E. coli-B. subtilis* shuttle vectorLab stockp43NMK-N*gfp*pP43NMK harboring *gfp* gene under the control of P~43~ promoterLab stock ([@bib42])p43NMK-*pfkA-alsSD*pP43NMK harboring *pfkA*, *alsS,* and *alsD* gene under the control of P~43~ promoterThis studypHT-*OVA*-*gfp*pHT01 harboring *gfp* and *OVA* gene under the control of P~43~ promoterThis studyp7S6pMD18-T containing lox71-spe-lox66 cassetteLab stock

2.2. Culture media and conditions {#sec2.2}
---------------------------------

Luria--Bertani (LB) agar plate and LB medium was used for the activation of glycerol stock strain and the cultivation of seed culture. M9 medium was used for growth curve determination and ribonucleic acid production. The medium consisted of 4 ​g/L glucose, M9 salts solution, trace element solution, 100 ​mM CaCl~2~, 1.0 ​mM MgSO~4~, 50 ​mM FeCl~3~, and tryptophan with a final concentration of 0.1‰. M9 salts solution 5× stock included 85.44 ​g/L Na~2~HPO~4~·12H~2~O, 15 ​g/L KH~2~PO~4~, 5 ​g/L NH~4~Cl, and 2.5 ​g/L NaCl. Trace elements 100× stock solution contained 100 ​mg MnCl~2~·4H~2~O, 170 ​mg ZnCl~2~, 43 ​mg CuCl~2~·2H~2~O, 60 ​mg CoCl~2~·6H~2~O, 60 ​mg Na~2~MoO~4~·2H~2~O. The concentrations of these stock solutions were 1× in the final media. The bioproduction of acetoin and proteins (GFP and ovalbumin) was carried out in the media containing 12 ​g/L yeast extract, 6 ​g/L tryptone, 2.5 ​g/L KH~2~PO~4~, 12 ​g/L K~2~HPO~4~∙3H~2~O, 6 ​g/L (NH~4~)~2~SO~4~, 3 ​g/L MgSO~4~∙7H~2~O, and 60 ​g/L glucose ([@bib50]). All strains were grown at 37 ​°C and 220 ​rpm.

2.3. Growth curve determination {#sec2.3}
-------------------------------

The culture for growth curve measurement was implemented in 250 ​ml shake flasks containing 18 ​ml of medium with 3 biological replicates. A spectrophotometer was used to monitor cell growth by measuring the optical density at 600 ​nm (OD~600~). Single colony was cultured in LB seed medium for 2--4 ​h until OD~600~ was between 0.3 and 1.0. Four dilutions (250×, 500×, 1000×,2000×) of the LB seed medium were prepared in M9 medium. Incubated the M9 precultures for 10--12 ​h. Measured OD~600~ of the M9 precultures and selected the preculture with OD~600~ between 0.5 and 1.0 to start the shake flask inoculation experiment to ensure that the selected preculture was in exponential phase. The starting OD~600~ of each shake flask was controlled between 0.03 and 0.05 by calculating the amount of the preculture added into each shake flask. Samples were taken every 2 ​h and diluted appropriately to measure the OD~600~.

2.4. Adaptive laboratory evolution {#sec2.4}
----------------------------------

Wild type BS168 was evolved in M9 medium and kept growing at continuous exponential phase at 37 ​°C, 220 ​rpm, referring to the method of LaCroix et al. for ALE ([@bib21]). The difference is that cultures propagated to the next cultures were from the shake flasks having the highest terminal OD~600~ in six parallel shake flasks instead of multiple replicate experiments. Ideally, beneficial mutations were enriched in the last populations. Cultures were propagated in exponential phase from the starting strain of wild type BS168 and the strains grown increasingly faster with the evolution. Therefore, the growth time in shake flasks of each culture was 12 ​h initially with gradually decrease culture time in multiple rounds shake flask cultivation. Precultures were grown in the same condition with growth curve determination. Experimentally growing cell in the culture were taken for inoculation. The amount of populations added to the next cultures were calculated by controlling the starting OD~600~ of each shake flask between 0.03 and 0.05. A total of 40 populations have been evolved, with more than 1,000 generations passed down. Starting from the 15th cultures, all evolutionary intermediates were frozen. The evolved strains A28 and A40 were obtained from the evolved populations as follows: The shake flask with the highest final OD~600~ was selected from the six parallel shake flasks culture. The culture solution containing evolved populations was spread on solid LB agar plate. After incubated at 37 ​°C for 10 ​h, the single colony with the largest diameter was picked as the representative strain of evolution. Strains A28 and A40 were selected by this method. At the end of the ALE experiment, the growth curves of the several representative populations were determined and the specific growth rates were calculated.

2.5. RNA content determination {#sec2.5}
------------------------------

M9 medium was used for cell growth. M9 precultures in the logarithmic growth phase was transferred to 250 ​ml shake flasks with 50 ​ml medium. The amount of preculture added to the shake flasks was calculated by controlling the starting OD~600~ of each shake flask between 0.03 and 0.05. Each experimental strain had two parallel samples at each sampling point. They were incubated in a shaker at 37 ​°C and 220 ​rpm. Samples were taken after cultivating for 6 ​h, 8 ​h, 10 ​h and 12 ​h. For a shake flask samples, 40 ​ml culture was dried at 105 ​°C for 8 ​h to calculate dry cell weight, and 1 ​ml culture was used to obtain OD~600~. For detection of A~260~, 2--4 ​ml of cultures was taken appropriately as a sample according to OD~600~. The samples were centrifuged to collect cells. Then the cells were resuspended in 50 ​mM PBS buffer solution and washed twice. Next, 0.8 ​ml 50 ​mM PBS buffer solution was used for resuspended followed by adding 3.2 ​ml 0.25 ​M HClO~4~ solution that was pre-cooled at 4 ​°C. After 15 ​min incubation at 4 ​°C, the precipitate was collected by centrifugation, followed by incubation at 70 ​°C for 15 ​min with 2 ​ml 0.5 ​M HClO~4~ solution for lysing the cell and releasing RNA. The supernatant after centrifugation was taken to determine A~260~. A spectrophotometer was used to measure the optical density at 600 ​nm and 260 ​nm to obtain OD~600~ and A~260~.

RNA content was calculated according to the following formula:$$RNA\% = \frac{DW_{RNA}}{DCW}\  = \frac{A_{260}\  \times \ 0.03365}{M\  \times \ DCW} \times 100\%$$where DW~RNA~ is the dry weight of RNA. A~260~ is the optical density at 260 ​nm. 0.03365 is a constant in the formula. M is the volume of the samples (ml). OD~600~ is the optical density at 600 ​nm. DCW is the dry cell weight (g/ml).

2.6. Acetoin content determination {#sec2.6}
----------------------------------

Acetoin fermentation was performed in the fermentation medium. Three parallel experiments were set up for each strain of the experiment. Single colonies on LB agar plates were picked and inoculated into 5 ​ml LB medium. They were incubated in a shaker at 37 ​°C and 220 ​rpm for 10 ​h. Then 2.5 ​ml of seed solution was added into a 250 ​ml shake flask with a total culture volume of 25 ​ml. After 32 ​h of fermentation, 1 ​ml of the culture sample was centrifuged at 14000 ​rpm for 5 ​min followed by collecting supernatant. In order to remove soluble protein, four volumes of H~2~SO~4~ solution with a concentration of 20 ​mM was added. After centrifugation at 14000 ​rpm for 15 ​min, the supernatant was harvested and measured by high performance liquid chromatography (HPLC) for acetoin content determination. HPLC (Agilent 1200 Series, USA) was equipped with an Aminex HPX-87H Column (300 ​× ​7.8 ​mm) with a UV detector (210 ​nm). 10 ​mM H~2~SO~4~ was used as mobile phase and the flow rate was 0.5 ​ml/min. The retention time for acetoin was 21.8 ​min. Standard solutions of different concentrations were prepared, and a standard curve was prepared to calculate the concentration of acetoin.

2.7. Fluorescence determination {#sec2.7}
-------------------------------

The fluorescence intensity of strains was characterized based on previous methods ([@bib11]). For each strain, three colonies were picked, inoculated and cultured in parallel into 24 deep well plates with 1.5 ​ml of medium at 37 ​°C, 220 ​rpm for 14 ​h. During fermentation, the samples were taken every 2 ​h and then diluted to 200 ​μL on 96-well microtiter plate with fresh medium. Fluorescence emissions and OD~600~ were detected on the 96-well microtiter plate using a Cytation 3 Multi-Mode Reader (BIOTEK). The excitation wavelength was 488 ​nm and the emission wavelength was 523 ​nm. The fluorescence intensity normalized by OD~600~ was used to characterize the fluorescence intensity of the strain.

2.8. Data statistics and analysis {#sec2.8}
---------------------------------

Origin was used to fit the growth curve and calculate the specific growth rate (μ). The "Boltzmann" function in the function category "Growth/Sigmoidal" was selected for nonlinear curve fitting. The fitting curves were derived and processed to obtain the specific growth rates. The maximum value was used for the specific growth rate for a strain. By this method, the specific growth rate of the wild type BS168 was calculated as 0.49 h^-1^, which was in accordance with specific growth rate 0.49 h^-1^ in the reference ([@bib12]).

3. Results {#sec3}
==========

3.1. Improving *B. subtilis* growth through rational gene knockout {#sec3.1}
------------------------------------------------------------------

Knocking out of specific genes of *B. subtilis* can affect its growth rate ([@bib12]). Therefore, genes that have been reported to improve cell growth after deletion were selected, which were knocked out individually using homologous recombination on the basis of wild type BS168. Gene *oppD* was knocked out successfully and the growth curve were measured for specific growth rates calculation. The results showed that the specific growth rate of *oppD* deletion strain (BS01) was 15.37% higher than the wild type strain BS168, reaching 0.56 h^-1^ ([Fig. 2](#fig2){ref-type="fig"}a).Fig. 2Effects of gene knockout and ALE on *B. subtilis* cell growth. (a). Effects of gene knockout on *B. subtilis* cell growth. BS01, BS02, BS03 were obtained by gene knockout of *oppD*, *hag*, and *flgD* on the basis of BS168, respectively. (b). Effects of ALE on *B. subtilis* cell growth. Strains A28 and A40 were obtained by 28 rounds culture with the starting strain BS168 passaged approximate 800 generations and 40 rounds culture with the starting strain BS168 passaged approximate 1000 generations during ALE, respectively. (c). Effects of ALE in combination with gene knockout on *B. subtilis* cell growth. Strains A4001, A4002 and A4003 were derived from evolutionary strain A40 with gene *oppD, hag* and *flgD* deletion, respectively. (d). Comparison of specific growth rates of the five strains with gradient increase of specific growth rate. BS168: wild type strain *B. subtilis* 168; BS03 is the representative of knockout strains (*flgD* gene deletion); A28 and A40 are adaptively evolved strains; A4003 represents combined strains (A40 with *flgD* deletion).Fig. 2

In addition, some cellular functions for industrially cultivated *B. subtilis* may not be necessary for the growth, such as flagellin based mobility and cold shock regulation. However, expression levels of relevant proteins with such functions are high ([@bib4]; [@bib5]). For instance, the genes *hag* and *flgD* encoding flagellin protein and flagellar hook cap were not essential for industrial cultivation of *B. subtilis*, however, expression level of Hag and FlgD is high ([@bib5]). Therefore, *hag* and *flgD* genes were knocked out respectively, yielding strains BS02 and BS03. Their specific growth rates reached 0.61 h^-1^ and 0.66 h^-1^, increased by 24.18% and 36.46% compared with the starting strain BS168, respectively ([Fig. 2](#fig2){ref-type="fig"}a).

3.2. Accelerating *B. subtilis* growth through ALE {#sec3.2}
--------------------------------------------------

ALE was used for growth rate optimization to obtain evolved strains with increased specific growth ([@bib34]; [@bib16]). The starting strain of ALE was wild type strain BS168. Throughout the whole ALE process, the starting strain BS168 was propagated over 1,000 generations. Frozen stocks of evolution intermediates and the end-point strains from the 15 th cultures to the end were saved. After 28 populations were propagated, the specific growth rate of the strains increased significantly (the specific growth rate increased more than 30%). The 28 th cultures were harvested and named A28. Similarly, the representative strain A40 was obtained ([Fig. 2](#fig2){ref-type="fig"}b). Their specific growth rates of A28 and A40 were 0.68 h^-1^ and 0.70 h^-1^, increased by 39.88% and 43.53% compared to the starting strain BS168, respectively.

3.3. Combining ALE and gene knockout for improving *B. subtilis* growth rate {#sec3.3}
----------------------------------------------------------------------------

In order to further improve growth rate, on the basis of evolved strain A40, three genes *oppD, hag, flgD* were further knocked out, resulting combined strains A4001, A4002, A4003. Their growth curve and specific growth rate was determined ([Fig. 2](#fig2){ref-type="fig"}c). The specific growth rate of strains A4001, A4002, A4003 reached 0.64 h^-1^, 0.69 h^-1^, 0.75 h^-1^, raised by 30.39%, 41.08%, 54.69% compared with wide type strain BS168, respectively. And specific growth rate of strain A4003 was 7.76% higher than A40, which reached the highest specific growth rate of all the strains obtained currently.

In order to test the efficiency of engineered strains with increased growth rate for biochemical and recombinant protein production, five representative strains for each experimental stage were selected, including BS168 (wild type strain BS168, μ ​= ​0.49 h^-1^), BS03 (BS168*ΔflgD*, μ ​= ​0.66 h^-1^), A28 and A40 (evolutionary strains, μ~A28~ ​= ​0.68 h^-1^, μ~A40~ ​= ​0.70 h^-1^), and A4003 (evolution strain A40 knocked out *flgD* gene, μ ​= ​0.75 h^-1^), which have gradient increase of specific growth rate ([Fig. 2](#fig2){ref-type="fig"}d). Therefore, the further application of these strains for bioproduction was tested.

3.4. Bioproduction tests of fast-growing strains {#sec3.4}
------------------------------------------------

To demonstrate the effectiveness of increased growth for enhancing the efficiency of bioproduction, growth-related products were selected for testing as follows: 1) The content of intracellular product RNA, 2) extracellular product acetoin, and 3) recombinant proteins, green fluorescent protein (GFP) and ovalbumin.

### 3.4.1. Bioproduction of RNA using fast-growing strains {#sec3.4.1}

RNA is ubiquitous in animals and plants as one of the most basic substances of life ([@bib20]). RNA and its monomer nucleotide have broad applications in medicine, food processing industry, especially as a key functional nutrition factor in infant milk powder. The current production method of industrial ribonucleic acid is extracted from yeast. It has been demonstrated that there is a linear relationship between the RNA content of *B. subtilis* growth rate ([@bib10]). Take these factors into account, RNA was selected as an example for intracellular compound production in five *B. subtilis* with gradient increase of specific growth rate obtained in this work. OD~600~ of the was five *B. subtilis* also measured to monitor their growth ([Fig. 3](#fig3){ref-type="fig"}a). It showed that the maximum RNA content appears in the logarithmic growth phase, which was 6--8 ​h for engineered strains and around 8--10 ​h for wild type strain BS168. The maximum RNA content of each strain was used for comparison. As expected, the content of RNA of these strains increased with the increase of specific growth rate ([Fig. 3](#fig3){ref-type="fig"}b). The RNA content of strains BS03, A28, A40, A4003 raised to 6.54%, 6.78%, 7.88% and 8.49%, which increased 6.34%, 10.31%, 28.07% and 38.09% compared to BS168, respectively (6.15%, [Fig. 3](#fig3){ref-type="fig"}b). Therefore, the purpose of increasing the RNA content of *B. subtilis* can be achieved by controlling the growth rate. The above results may be useful for improving bioproduction of RNA for industrial production.Fig. 3Bioproduction of RNA using the *B. subtilis* strains with gradient increase of specific growth rates. (a). The growth curves of *B. subtilis* with different specific growth rates. (b). The maximum RNA content of stains with gradient increase specific growth rates. For each tested strain, the maximum RNA content measured among four sampling points was selected as the RNA content of the strain.Fig. 3

### 3.4.2. Bioproduction of acetoin using fast-growing strains {#sec3.4.2}

Acetoin is an important edible spice, which is also widely used in functional materials manufacturing, pharmaceutical production and chemical synthesis ([@bib3]; [@bib25]; [@bib45]). The biosynthesis of acetoin was chosen as the second example to test the effectiveness of growth rate engineering for extracellular product synthesis. Based on biosynthesis pathway of acetoin, three genes including *pfkA*, *alsS* and *alsD* were chosen to be overexpressed in the strains with gradient increase of specific growth rates ([Fig. 4](#fig4){ref-type="fig"}a). Four strains BS04, A2801, A4006 and A4007 derived from BS168, A28, A40 and A4003 were successfully obtained. Derivative strain from BS03 strain was not obtained because of the difficulty in plasmid transformation. The results showed an expected trend that the acetoin yield increased as the specific growth rate increased ([Fig. 4](#fig4){ref-type="fig"}b). Strain A4007 had a maximum increase in acetoin production. The maximum acetoin content of it at 32 ​h was 8.21 ​g/L compared with 7.79 ​g/L of BS04 derived from wild type strain. Noticeably, the acetoin synthesis rate of strains with increased growth rate was faster than BS04 during 24 ​h ([Fig. 4](#fig4){ref-type="fig"}c). The acetoin synthesis rates of A2801, A4006 and A4007 were 40.91%, 50.00% and 54.55% higher than BS04 (0.22 ​g/L/h), reaching 0.31 ​g/L/h, 0.33 ​g/L/h, and 0.34 ​g/L/h, respectively. This result proved that increasing the specific growth rate of the strain can improve the bioproduction rate of acetoin. The reasons why the fast-growing strain got both high biomass and bioproduct was that more glucose was consumed at each time point compared to wild type strain. The same initial glucose (60 ​g/L) was provided for BS04 and A4007 (using wild type strain BS168 and fast-growing strain A4003 as chassis for acetoin production, respectively). At 24 ​h, the residue glucose for BS04 was 10.51 ​g/L ([Fig. 4](#fig4){ref-type="fig"}d). In comparison, the residue glucose for A4007 was 5.68 ​g/L. Therefore, the fast-growing strain A4007 consumed 4.83 ​g/L more glucose to obtain both higher biomass and bioproduct. In addition, the concentrations of by-product lactate for both BS04 and A4007 were lower than 1 ​g/L, which should not severely affect cell growth and bioproduction ([Fig. 4](#fig4){ref-type="fig"}e)Fig. 4Bioproduction of acetoin using *B. subtilis* strains with gradient increase of specific growth rates. (a). The biosynthetic pathway of acetoin. Three genes (*pfkA*, *alsS* and *alsD*) were chosen to be overexpressed through a plasmid p43NMK-*pfkA-alsSD* under the control of strong constitutive promoter P~43~ in the strains with gradient increase of specific growth rates. (b). The acetoin production by BS04, A2801, A4006 and A4007. (c). Synthesis rate of acetoin after fermentation for 24 ​h. (d). The residue glucose at 24 ​h. (e). The lactate concentration of BS04, A2801, A4006 and A4007 at 24 ​h.Fig. 4

### 3.4.3. Bioproduction of heterologous protein using fast growing strains {#sec3.4.3}

Both GFP and ovalbumin were used as examples for characterizing production efficiency of heterologous protein by *B. subtilis* strains with gradient increase of specific growth rates. Ovalbumin is the main component of egg white. Efficiently fermentatively producing ovalbumin is the one possible direction of future foods for protein supply transition from animal-based supply to fermentation-based supply to meet the increasing global protein demand. Strains with improved growth rate showed 1.53%, 5.10%, 5.75% and 9.47% increase in relative fluorescence intensity compare with control for GFP expression ([Fig. 5](#fig5){ref-type="fig"}a). In parallel, ovalbumin fused with GFP were expressed in *B. subtilis* strains with gradient increase of specific growth rates. After fermentation for 40 ​h, the relative fluorescence intensity of each strain was determined for characterizing ovalbumin expression level ([Fig. 5](#fig5){ref-type="fig"}b). In general, the evolved strains (A2803, A4010) and evolved strain with *flgD* gene knockout (A4011) showed improved ability to express ovalbumin than wild type (BS08) with an increase around 20% ([Fig. 5](#fig5){ref-type="fig"}b).Fig. 5Bioproduction of heterologous protein using *B. subtilis* strains with gradient increase of specific growth rates. (a). The relative fluorescence intensity of five specific growth rate gradient strains with GFP expression. (b). The relative fluorescence intensity of five specific growth rate gradient strains with OVA expression fused with GFP. The ∗ and ∗∗ indicate *P* ​\< ​0.05 and *P* ​\< ​0.01 relative to control strain BS06 and BS08, respectively.Fig. 5

4. Discussion and conclusions {#sec4}
=============================

In this study, we obtained fast-growing a series of *B. subtilis* with fast growth phenotype compared to starting strain *B. subtilis* 168. Strain A4003 obtained via adaptive evolution and *flgD* gene knockout has the highest specific growth rate, reaching 0.75 h^-1^ in chemically defined M9 medium, which is 54.69% higher than starting strain. Fast-growing strain A4003 can be potentially used as chassis for enhancing biochemical and heterologous protein production, which was demonstrated using RNA, acetoin, GFP, and ovalbumin as examples for intracellular product, extracellular metabolite, and recombinant proteins production. Different from ALE-based growth rate optimization in *E. coli*, both ALE and rational gene knockout were performed for enhancing *B. subtilis* growth rate ([@bib47]; [@bib2]; [@bib6]; [@bib33]). In addition, ALE process was modified to enrich all the improved mutants into a shake flask culture to obtain the fast-growing strain rather than obtaining parallel mutant library.

Many studies have analyzed the metabolic mechanism of ALE through whole genome sequencing and comparative genome analysis, such as the metabolic mechanism of *Saccharomyces cerevisiae*'s adaptability to acids ([@bib29]). For further understanding the mechanism about how evolved strains increased their specific growth rate, we plan to perform whole-genome sequencing and comparative genomic analysis of the evolved strains with starting strains. Frozen evolutionary intermediates are the basis of a further understanding of the beneficial mutations of ALE. After identifying the key mutation sites, reverse engineering will be performed to verify the contribution of individual mutations to the fast-growing phenotype.

For the phenomenon that different effects on specific growth rate after knocking out *oppD* and *hag* in A40 and in wild type BS168, we speculated that the differences were caused by certain genetic mutations occurred in the *oppD* or *hag* related pathway genes in strain A40 during the evolution. The specific genetic mutations in the metabolic network led to this result may be found through whole genome sequencing and comparative genomic analysis. Although it is challenging to comprehensively determine the specific mechanism of evolution, comparative genomic analysis is effective to determine the impact of high-frequency changes and individual genetic changes on ALE. In addition, the application of fast-growing *B. subtilis* chassis cell to increase product yield can be improved by combining with other effective strategies, such as strategies for improving recombinant protein production. It has been demonstrated that optimizing codons, promoters, signal peptides and balancing protein synthesis and secretion in *B. subtilis* were effective strategies for improving recombinant protein production ([@bib7]; [@bib24]; [@bib39]). Further applying above strategies in fast-growing *B. subtilis* has potential for further improvement for recombinant protein production.

The application of fast-growing *B. subtilis* chassis cell for different products may be different. The productivity of growth-coupled products should increase with the increased specific growth rate. For non-growth-coupled products, cell growth and bioproduction needs to be balanced for improved production. Noticeably, increased specific growth rate of *B. subtilis* may shortened the fermentation period, therefore, the productivity can be potentially improved for non-growth-coupled products. Furthermore, based on shortened fermentation period, the utilization efficiency of production equipment can also be improved, which can reduce the cost of bioproduction.

In conclusion, we obtained *B. subtilis* chassis cell with faster growth phenotype through rational gene knockout or ALE. Then the chassis cell with faster specific growth rate was obtained by combining gene knockout and ALE. We used RNA, acetoin, GFP and ovalbumin to verified the enhancement of chassis cell for intracellular product, extracellular product, and recombinant proteins production. The developed fast-growing *B. subtilis* strains and strategies used for developing these strains should be useful for improving bioproduction efficiency and constructing other industrially important bacterium with faster growth phenotype.
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